Charta Health Raises $55M to Bridge AI Coding Gaps for Providers and Payers

Charta Health has closed a $55 million Series B to expand its AI-driven chart-review platform, targeting a market where billing disputes and coding errors drain billions from the U.S. healthcare system. Insight Partners led the round, joined by QuantumLight and returning backers Madrona, Bain Capital Ventures, and South Park Commons, according to reporting from Unite.AI. The financing follows Charta’s $22 million Series A in mid-2025 and comes as the company shifts from provider-only tools to a dual-sided platform serving both healthcare systems and insurers—a bet on whether AI can reconcile conflicting priorities in medical billing.

The capital will accelerate AI integration for providers, where Charta’s software already scans every patient chart before billing to catch discrepancies against coding rules, payer requirements, and internal clinical standards. The company’s payer-focused tools, introduced alongside the round, aim to identify unsupported diagnoses or missing conditions in claims—built in collaboration with one of the nation’s largest insurers (unnamed). This dual approach reflects an attempt to align AI outputs across two opposing incentives: providers pushing for higher reimbursements and payers demanding rigorous documentation.

Why it matters Medical coding is a systemic inefficiency. Every year, providers lose billions to claim denials, while payers spend heavily on audits and appeals. Charta’s model uses large language models to analyze unstructured data—scanned orders, lab results, free-text notes, even images—and generate a single, standardized interpretation of a patient’s chart before any claim is filed. The payer tools, now in development, apply the same AI to retrospective coding, risk-adjustment validation, and audit workflows. Charta claims 98% accuracy in its automated second-pass coding, where AI flags charts for human review based on potential value—a threshold that suggests the company is prioritizing efficiency over absolute precision.

The challenge is deliberate. Charta’s leadership has described the core issue as establishing a "ground truth" in medical records—one that can justify a provider’s billing while also surviving a payer’s audit. But the commercial test will be whether humans, still required to validate AI suggestions, trust the system enough to act on them. Insight Partners’ Jeff Horing framed this as "the opportunity in AI for healthcare," but the execution isn’t guaranteed. If the AI misses too many errors, providers may dismiss its alerts; if it overflags, payers could reject valid claims. The $55 million round signals confidence in Charta’s ability to navigate this balance, but the proof will come when its largest insurer partner fully deploys the system.

What’s next Charta’s expansion into payer tools distinguishes it from other AI-driven healthtech startups this year, such as those building new clinical workflows or enterprise agents. Unlike those plays, Charta isn’t inventing a new process—it’s refining an existing one where AI’s role is still debated. Watch for three key developments: 1. Insurer adoption. Denial-rate improvements. Human oversight dynamics. Charta’s model depends on clinicians validating AI flags, but if automation becomes too dominant, it could introduce new compliance risks. How the company balances speed with accountability will determine whether its "trusted interpretation" becomes standard—or just another automated suggestion.

The funding reflects a broader shift: AI in healthcare is increasingly about augmenting human judgment in high-stakes, low-margin processes. For Charta, the question isn’t whether AI can read a chart—but whether it can do so reliably enough to reshape how billions in claims are resolved.

Sources: unite.ai